glp 1 blindness A potentially blinding condition is a very rare side effect of the GLP-1 receptor agonist semaglutide (Ozempic, Wegovy, Rybelsus), the European Medicines Agency (EMA) concluded. https://www.medpagetoday.com/ophthalmology/generalophthalmology/115938?trw=no A Georgia woman said her

doi: 10.1001/jamainternmed.2018.2933 134 Perez-Montes DE OcaAPelliteroSPuig-DomingoM

22 There is, however, no evidence that pregnancy in any significant way stimulates their development or alters the biological potential of pre-existent nevi

A direct head-to-head trial (NCT06662383, 800 patients) is underway with results in December 2026

The Favorable Impact of Gh-Igf1 on Radiation Damage Repair in Adjacent Tissues Radiotherapy could kill tumor cells and improve the survival rate of patients, but meanwhile cause inevitable damage to adjacent tissues in the radiotherapy area unavoidable

It adds that a provider should cover treatment goals, realistic expectations, route preference and monitoring frequency before therapy starts

Note that many Aetna plans explicitly exclude weightloss medications and related services entirely